Novartis AG is 5.0x more valuable than REGENERON PHARMACEUTICALS, INC. by market capitalization ($283.13 B vs $56.80 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | REGN | NVS |
|---|---|---|
| Market cap | $56.80 B | $283.13 B |
| US-listed rank | #292 | #47 |
| Revenue (latest FY) | $14.34B | - |
| Net income (latest FY) | $4.50B | - |
| Net margin | 31.4% | - |
| P/E (trailing FY) | 12.6 | - |
| SEC filings | 985 | 947 |
Novartis AG is 5.0x more valuable than REGENERON PHARMACEUTICALS, INC. by market capitalization ($283.13 B vs $56.80 B).
Full pages: REGENERON PHARMACEUTICALS, INC. and Novartis AG, or browse the full rankings.